Product Information

METHYLPHENIDATE 20 MG TABLET is a generic product labeled by SpecGx LLC, priced at $0.2102 per EA under NDC 00406114601. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Nov 27, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METHYLPHENIDATE 20 MG TABLET

Methylphenidate Hydrochloride
$0.2102per EA
DEA Schedule CII

Strength

20 mg/1

Manufacturer

SpecGx LLC

NDC

00406114601

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA040300

FDA Approved

11/27/1998

TE Code

AB

On Market Since

11/27/1998

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for METHYLPHENIDATE 20 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 80.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2102 per EA
All-time high$1.1050 (Feb 12, 2014)
All-time low$0.1079 (Apr 17, 2024)
52-week high$0.2332
52-week low$0.1962
Median price$0.2681
Average price$0.4564
Largest weekly change+108.2% (Aug 21, 2024)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

-0.5%

1M

-0.5%

3M

+4.2%

6M

-1.5%

1Y

-9.4%

3Y

+23.5%

5Y

-1.0%

All

-80.2%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 34% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of METHYLPHENIDATE 20 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE 20 MG TABLET, manufactured by SpecGx LLC, is $0.2102 per EA (NDC 00406114601), effective Aug 19, 2026.

How has the price of METHYLPHENIDATE 20 MG TABLET changed over time?

Over the history we have for it, the NADAC for METHYLPHENIDATE 20 MG TABLET has declined 80.2%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE 20 MG TABLET?

Since Nov 28, 2013, the NADAC for METHYLPHENIDATE 20 MG TABLET has ranged from a low of $0.1079 (Apr 17, 2024) to a high of $1.1050 (Feb 12, 2014), with a median of $0.2681 per EA.

Are there cheaper alternatives to METHYLPHENIDATE 20 MG TABLET?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METHYLPHENIDATE 20 MG TABLET, is $0.1389 per EA — about 34% below METHYLPHENIDATE 20 MG TABLET.

Who manufactures METHYLPHENIDATE 20 MG TABLET?

METHYLPHENIDATE 20 MG TABLET (NDC 00406114601) is labeled by SpecGx LLC, and CMS classifies it as a generic product.